News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
221,459 Results
Type
Article (5025)
Company Profile (22)
Press Release (216412)
Section
Business (82318)
Career Advice (460)
Deals (15063)
Drug Delivery (8)
Drug Development (19144)
Employer Resources (30)
FDA (3681)
Job Trends (3914)
News (120320)
Policy (7514)
Tag
Academia (290)
Alliances (14728)
Alzheimer's disease (212)
Approvals (3676)
Artificial intelligence (17)
Bankruptcy (95)
Best Places to Work (2858)
Biotechnology (24)
Breast cancer (21)
Cancer (223)
Career advice (391)
Cell therapy (50)
Clinical research (15704)
Collaboration (76)
Compensation (61)
COVID-19 (296)
C-suite (43)
Data (241)
Diagnostics (1997)
Earnings (39833)
Employer resources (31)
Events (36908)
Executive appointments (113)
FDA (3780)
Funding (74)
Gene therapy (23)
GLP-1 (99)
Government (407)
Healthcare (5009)
Infectious disease (306)
Inflammatory bowel disease (21)
Interviews (53)
IPO (7738)
Job creations (1120)
Job search strategy (360)
Layoffs (98)
Legal (2323)
Lung cancer (24)
Manufacturing (24)
Medical device (3837)
Medtech (3838)
Mergers & acquisitions (7351)
Metabolic disorders (64)
Neuroscience (254)
NextGen Class of 2024 (1677)
Non-profit (724)
Northern California (461)
Obesity (34)
Opinion (28)
People (24152)
Phase I (4671)
Phase II (6829)
Phase III (5431)
Pipeline (180)
Postmarket research (628)
Preclinical (1830)
Press Release (66)
Radiopharmaceuticals (103)
Rare diseases (31)
Real estate (1870)
Regulatory (4988)
Research institute (299)
Resumes & cover letters (68)
Southern California (353)
Startups (1008)
United States (3818)
Vaccines (25)
Date
Last 7 days (416)
Last 30 days (1019)
Last 365 days (11140)
2024 (9862)
2023 (13229)
2022 (18698)
2021 (19719)
2020 (18278)
2019 (13270)
2018 (10251)
2017 (10040)
2016 (9181)
2015 (12140)
2014 (9590)
2013 (7717)
2012 (8336)
2011 (8807)
2010 (8640)
Location
Africa (182)
Arizona (48)
Asia (11308)
Australia (1551)
California (939)
Canada (425)
China (26)
Colorado (35)
Connecticut (48)
Europe (23975)
Florida (123)
Georgia (19)
Idaho (23)
Illinois (72)
Indiana (34)
Japan (25)
Kansas (23)
Maine (33)
Maryland (125)
Massachusetts (809)
Michigan (57)
Minnesota (96)
New Jersey (305)
New York (275)
North Carolina (233)
Northern California (461)
Ohio (35)
Pennsylvania (203)
South America (273)
Southern California (353)
Texas (107)
Utah (29)
Washington State (91)
221,459 Results for "orion corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Orion’s collaboration partner Bayer submits application for third indication of darolutamide in the EU
October 14, 2024
·
1 min read
Press Releases
Orion Corporation: Managers’ transactions – Niclas Lindstedt
August 23, 2024
·
1 min read
Press Releases
Orion Corporation: Managers’ transactions – Hao Pan
August 15, 2024
·
1 min read
Press Releases
Orion Corporation’s financial reporting and Annual General Meeting in 2025
August 8, 2024
·
1 min read
Press Releases
Orion’s collaboration partner Bayer submits application to U.S. FDA for third indication of darolutamide which has become the first ever Orion-originated blockbuster
September 26, 2024
·
2 min read
Business
Orion is developing the Finnish life science industry in a unique collaboration project
Orion is participating in a project led by the University of Turku for which Business Finland recently granted 11.7M€ funding.
June 3, 2024
·
4 min read
Business
Merck and Orion Announce Mutual Exercise of Option Providing Merck Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Merck and Orion Corporation (“Orion”) today announced that notice has been provided of the mutual exercise of an option to convert the companies’ ongoing co-development and co-commercialization agreement for opevesostat (MK-5684/ODM-208), an investigational CYP11A1 inhibitor, and other candidates targeting CYP11A1 into an exclusive global license for Merck.
July 1, 2024
·
8 min read
Press Releases
Inside information: Orion terminates ODM-111 development program due to narrow therapeutic window of the molecule
October 25, 2024
·
2 min read
Press Releases
Orion publishes Interim Report for January–September 2024 and holds a webcast on 29 October 2024
October 15, 2024
·
1 min read
Press Releases
Orion and Aitia enter AI-Driven Drug Discovery and Drug Simulation Collaboration in Oncology
September 26, 2024
·
4 min read
1 of 22,146
Next
